Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 04:00PM ET
0.9600
Dollar change
-0.0500
Percentage change
-4.95
%
Index- P/E- EPS (ttm)-1.25 Insider Own19.93% Shs Outstand30.71M Perf Week34.28%
Market Cap29.48M Forward P/E- EPS next Y-1.00 Insider Trans17.31% Shs Float24.59M Perf Month32.76%
Income-6.00M PEG- EPS next Q-0.52 Inst Own14.99% Short Float6.70% Perf Quarter-4.95%
Sales0.00M P/S- EPS this Y16.92% Inst Trans- Short Ratio0.35 Perf Half Y-65.59%
Book/sh-0.37 P/B- EPS next Y7.41% ROA-33.38% Short Interest1.65M Perf Year-83.87%
Cash/sh0.03 P/C31.36 EPS next 5Y- ROE-202.12% 52W Range0.46 - 6.30 Perf YTD-83.59%
Dividend Est.- P/FCF- EPS past 5Y32.71% ROI- 52W High-84.76% Beta1.37
Dividend TTM- Quick Ratio0.82 Sales past 5Y0.00% Gross Margin- 52W Low106.85% ATR (14)0.20
Dividend Ex-Date- Current Ratio0.82 EPS Y/Y TTM56.61% Oper. Margin0.00% RSI (14)57.01 Volatility49.56% 32.19%
Employees12 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price15.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q134.04% Payout- Rel Volume0.65 Prev Close1.01
Sales Surprise- EPS Surprise120.00% Sales Q/Q- EarningsJun 17 BMO Avg Volume4.65M Price0.96
SMA2036.85% SMA5037.27% SMA200-56.28% Trades Volume3,025,228 Change-4.95%
Date Action Analyst Rating Change Price Target Change
Feb-14-22Initiated H.C. Wainwright Buy $25
Oct-02-24 04:05PM
Oct-01-24 02:05PM
07:50AM
Sep-18-24 07:50AM
Sep-12-24 04:05PM
12:09PM Loading…
Sep-11-24 12:09PM
07:50AM
Sep-10-24 07:50AM
Sep-09-24 07:50AM
Jul-18-24 07:56AM
Jun-14-24 09:52PM
Jun-03-24 08:00AM
May-30-24 08:00AM
May-28-24 08:00AM
07:27AM
08:00AM Loading…
May-24-24 08:00AM
May-21-24 07:39AM
May-17-24 04:33PM
May-15-24 08:00AM
Apr-24-24 08:00AM
Apr-10-24 08:00AM
Apr-09-24 08:00AM
Mar-19-24 06:52AM
Mar-07-24 08:00AM
Mar-06-24 08:00AM
Feb-27-24 08:00AM
Feb-07-24 08:00AM
Feb-06-24 08:30AM
Jan-30-24 10:48PM
Jan-04-24 08:45AM
08:55AM Loading…
Dec-28-23 08:55AM
Dec-20-23 08:40AM
Dec-06-23 09:31AM
09:00AM
Nov-30-23 07:00AM
Nov-03-23 08:31AM
Nov-01-23 10:49AM
Oct-25-23 09:15AM
Oct-20-23 09:15AM
Oct-18-23 09:00AM
Oct-11-23 09:10AM
Oct-04-23 09:00AM
Oct-03-23 09:00AM
Sep-08-23 07:00AM
Aug-31-23 11:54AM
08:21AM
Aug-25-23 02:33PM
Aug-18-23 12:21PM
Aug-16-23 08:36AM
Jul-10-23 07:00AM
Jun-27-23 08:05AM
May-25-23 09:00AM
May-19-23 11:38AM
May-15-23 08:00AM
Apr-27-23 05:33AM
Apr-17-23 07:45AM
Apr-10-23 07:29AM
Mar-30-23 08:45AM
Mar-15-23 09:15AM
Mar-14-23 06:27AM
Mar-09-23 04:56AM
Feb-23-23 08:00AM
Feb-11-23 07:13AM
Feb-09-23 11:09PM
Jan-24-23 09:07AM
Jan-23-23 12:06PM
08:41AM
Jan-20-23 12:15PM
Jan-18-23 08:47AM
Jan-10-23 09:00AM
Dec-19-22 06:16AM
Dec-08-22 09:25AM
Dec-02-22 10:00AM
Nov-30-22 08:04AM
Nov-21-22 05:10AM
Nov-15-22 08:00AM
Nov-10-22 09:00AM
Oct-31-22 07:54AM
Oct-21-22 09:00AM
Oct-14-22 07:13AM
Oct-12-22 09:00AM
Sep-28-22 09:15AM
Sep-14-22 09:20AM
Sep-07-22 09:25AM
Aug-17-22 10:13AM
Aug-05-22 02:41PM
Aug-04-22 09:00AM
Jul-21-22 08:23AM
Jul-05-22 09:00AM
Jun-29-22 09:00AM
Jun-24-22 09:00AM
Jun-23-22 07:40AM
May-18-22 09:15AM
May-06-22 03:02PM
Apr-13-22 08:00AM
Apr-12-22 04:30PM
Apr-07-22 08:30AM
Mar-29-22 05:44AM
Feb-28-22 08:00AM
Feb-23-22 08:00AM
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lustig MarcDirectorMay 14 '24Buy2.21902,9352,000,0012,542,935May 20 04:00 PM